Transfusion antenatally in pregnant women with sickle cell disease
Sickle cell disease is an inherited blood condition that can cause severe pain and health complications. During pregnancy, it can increase the risk of high blood pressure, early delivery, and smaller babies. Currently, most pregnant women only receive a blood transfusion if an emergency happens. This UK study is exploring a treatment called exchange blood transfusion. During this procedure, some of the mother's sickle blood cells are gently removed and replaced with healthy donor red blood cells. Researchers want to see if giving these transfusions every 6 to 10 weeks, starting before 18 weeks of pregnancy, is feasible to study on a wider scale. Participants are randomly placed into one of two groups: one receives regular planned transfusions alongside routine maternity care, while the other receives standard maternity care where transfusions are given only if needed.
Överblick
Vad handlar denna studie om?
Sickle cell disease is a lifelong blood condition that causes red blood cells to change into a rigid, sickle-like shape. These cells can get stuck in small blood vessels, blocking blood flow and oxygen. This leads to episodes of severe pain, known as sickle cell crises, and can cause damage to body organs. Pregnancy puts extra strain on the body, making painful crises more likely and increasing the chance of complications such as pre-eclampsia, premature birth, and low birth weight.
Managing sickle cell disease in pregnancy can be challenging. Some everyday sickle cell medicines, such as hydroxycarbamide, are not safe to take while pregnant. While blood transfusions are known to help, standard NHS care typically reserves them for sudden complications or emergencies. Researchers want to find out whether giving planned transfusions throughout pregnancy could safely protect mothers and their babies from serious problems.
This project is a feasibility trial run by Guy's and St Thomas' NHS Foundation Trust. It is testing 'exchange transfusions', where a special machine swaps sickle red blood cells for healthy donor cells every 6 to 10 weeks. Before launching a large nationwide study, the team needs to know if pregnant women are happy to take part and stay in the study. The findings will help doctors design better, safer maternity care for women living with sickle cell disease.
Viktiga punkter
- The study tests whether planned exchange blood transfusions during pregnancy help mothers with sickle cell disease and their babies.
- Half of the participants receive regular planned transfusions; the other half receive standard NHS maternity care.
- Transfusions begin before the 18th week of pregnancy and take place every 6 to 10 weeks.
- This is a feasibility study to check if pregnant women are happy to take part before running a larger national trial.
- Taking part is voluntary, and you can withdraw at any time without altering your standard NHS treatment.
Vem kan vara berättigad?
This study is open to pregnant women aged 18 and older who have a confirmed medical diagnosis of sickle cell disease (any genetic type). To join, you must be in the early stages of pregnancy—specifically, 18 weeks pregnant or less—and expecting a single baby.
You will not be able to take part if you were already receiving regular, long-term blood transfusions before you became pregnant. You also cannot join if you are unable to receive blood transfusions for medical, religious, or personal reasons, or if you are carrying twins or triplets.
Kan denna studie passa dig?
Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.
- I am aged 18 or over.
- I have been diagnosed with sickle cell disease (any type).
- I am currently 18 weeks pregnant or less.
- I am expecting one baby (not twins or triplets).
- I was not on a regular, planned transfusion programme before becoming pregnant.
- I am willing and able to receive blood transfusions.
Vad innebär deltagande?
If you decide to take part, you will be randomly placed by a computer into one of two groups. One group will receive planned exchange blood transfusions every 6 to 10 weeks, starting before the 18th week of pregnancy. The other group will receive standard NHS pregnancy care, where transfusions are only given if an emergency or sudden complication arises.
If you are in the transfusion group, you will visit the hospital for your exchange procedures. A small tube is placed into a vein in your arm, and a machine replaces sickle red blood cells with donor blood. Because the fluid used to prevent clotting can temporarily lower blood calcium, you may receive calcium supplements or a slow injection to keep you comfortable. Throughout your pregnancy and after your baby is born, the research team will track your health, your pain levels, any hospital stays, and your baby's growth and birth weight. Taking part lasts until after you give birth.
Potentiella risker och fördelar
Platser (7)
- Guy's och St Thomas' NHS Foundation TrustEndast stadLondon, England
- King's College Hospital NHS Foundation TrustEndast stadLondon, England
- St George’s University Hospitals NHS Foundation TrustEndast stadLondon, England
- St Mary's Hospital, Manchester University NHS Foundation TrustEndast stadGreater Manchester, England
- Whittington Health NHS TrustEndast stadLondon, England
- Imperial College Healthcare NHS TrustObekräftadLondon, England
- Universitetssjukhusen i Leicester NHS TrustObekräftadLeicester, England
Vanliga frågor
What is an exchange blood transfusion?
It is a procedure where a machine slowly removes some of your sickle red blood cells through a vein and replaces them with healthy donor red blood cells at the same time.
Can I choose which group I am placed in?
No. A computer randomly decides whether you receive planned regular transfusions or standard care. This ensures the trial results are completely fair and reliable.
Will I still get a transfusion if I am in the standard care group and need one?
Yes, absolutely. If you experience an emergency or your clinical team decides you need a blood transfusion, you will receive one straight away.
Is receiving donor blood in the UK safe?
Yes. Donor blood undergoes rigorous screening and precise cross-matching in the UK. The risk of catching an infection like hepatitis or HIV is exceptionally low.
Vad händer om jag ändrar mig om att delta?
You can leave the trial at any point. You do not need to give a reason, and your regular pregnancy and sickle cell care will continue as normal.
Hur du får reda på mer
Eugene Oteng-Ntim
Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.
Diskussion
Gemenskapsdiskussion
Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.